Healthcare and Pharmaceuticals industry

Global Glucagon Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

In the world economic growth, the Glucagon Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Glucagon market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Glucagon market size will be further expanded, we expect that by 2024, The market size of the Glucagon will reach XXX million $.

Glucagon is a hormone produced by alpha cells found in the pancreas is involved in regulating the blood sugar levels. It prevents the dropping down of blood sugar levels and also promotes the secretion of glucose from an amino acid. Glucagon is also used as a medication for treating various medical conditions and manufactured from proglucagon, encoded by the GCG gene process. Glucagon keeps the blood sugar level within the set levels and it can be administered by injection to restore the glucose lowered by insulin. Thus, Glucagon is crucial for an accurate blood sugar level. Moreover, Glucagon is widely used across the cardiogenic shock, emergency kits, diagnostic and motility, and other fields.

Rising prevalence of diabetes around the globe is predominantly fueling the market growth of glucagon. World Health Organization estimates that diabetes was the seventh leading cause of death in 2016. In 2016, an estimated 1.6 million deaths were directly caused by diabetes. Growth in the geriatric population, increasing per capita income, and improving healthcare facilities are some of the other factors augmenting the market growth of the glucagon over the forecast period.

From the geographical perspective, North America is expected to gain significant growth over the forecast period due to rising healthcare expenditure and the rapid introduction of advanced technologies in the region. For instance, in July 2019, the FDA has approved GVOKE, a glucagon injection for the treatment of low blood sugar (severe hypoglycemia) in children with diabetes who are at least two years of age. Xeris Pharmaceutical’s GVOKE is room-temperature, liquid, stable glucagon that is ready-to-use in an emergency as well.

Key Developments:

  • In July 2019, FDA approved Lilly's first nasal glucagon powder for the emergency treatment of severe hypoglycemia in children as well as adults with diabetes.
  • In February 2020, Fresenius Kabi announced the launch of its Glucagon Emergency Kit, an FDA-approved. It is a cost-effective alternative to treat severe hypoglycemic cases in people with diabetes. The kit composed of glucagon for Injection 1 mg and a prefilled glass syringe with 1 mL of sterile water for injection, USP.
  • In September 2019, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes. It is a first and only glucagon-like peptide-1 (GLP-1) analog in a pill for adults with type 2 diabetes who are not achieving their A1C goal with current antidiabetic treatment.

This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI

Section 1: Definition

Section (2 3): Manufacturer Detail

✑ Novo Nordisk
✑ Eli Lilly
✑ Fresenius Kabi
✑ Torrent Labs
✑ Taj Pharmaceuticals
✑ Xeris Pharmaceuticals

Section 4: Region Segmentation

✑ North America Country (United States, Canada)
✑ South America
✑ Asia Country (China, Japan, India, Korea)
✑ Europe Country (Germany, UK, France, Italy)
✑ Other Country (Middle East, Africa, GCC)

Section (5 6 7): Segmentation

Product Type Segmentation:
✑ Inject Glucagon
✑ Nasal Glucagon

Industry Segmentation:
✑ Emergency Kits
✑ General Use
✑ Diagnostic & Motility
✑ Cardiogenic Shock

Channel (Direct Sales, Distributor) Segmentation

Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion

Table of Contents

Section 1 Glucagon Product Definition

Section 2 Global Glucagon Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Glucagon Shipments
2.2 Global Manufacturer Glucagon Business Revenue
2.3 Global Glucagon Market Overview

Section 3 Manufacturer Glucagon Business Introduction
3.1 Novo Nordisk Glucagon Business Introduction
3.1.1 Novo Nordisk Glucagon Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 Novo Nordisk Glucagon Business Distribution by Region
3.1.3 Novo Nordisk Interview Record
3.1.4 Novo Nordisk Glucagon Business Profile
3.1.5 Novo Nordisk Glucagon Product Specification

3.2 Eli Lilly Glucagon Business Introduction
3.2.1 Eli Lilly Glucagon Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 Eli Lilly Glucagon Business Distribution by Region
3.2.3 Interview Record
3.2.4 Eli Lilly Glucagon Business Overview
3.2.5 Eli Lilly Glucagon Product Specification

3.3 Fresenius Kabi Glucagon Business Introduction
3.3.1 Fresenius Kabi Glucagon Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 Fresenius Kabi Glucagon Business Distribution by Region
3.3.3 Interview Record
3.3.4 Fresenius Kabi Glucagon Business Overview
3.3.5 Fresenius Kabi Glucagon Product Specification

3.4 Torrent Labs Glucagon Business Introduction
3.5 Taj Pharmaceuticals Glucagon Business Introduction
3.6 Xeris Pharmaceuticals Glucagon Business Introduction


Section 4 Global Glucagon Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Glucagon Market Size and Price Analysis 2014-2019
4.1.2 Canada Glucagon Market Size and Price Analysis 2014-2019
4.2 South America Country
4.2.1 South America Glucagon Market Size and Price Analysis 2014-2019
4.3 Asia Country
4.3.1 China Glucagon Market Size and Price Analysis 2014-2019
4.3.2 Japan Glucagon Market Size and Price Analysis 2014-2019
4.3.3 India Glucagon Market Size and Price Analysis 2014-2019
4.3.4 Korea Glucagon Market Size and Price Analysis 2014-2019
4.4 Europe Country
4.4.1 Germany Glucagon Market Size and Price Analysis 2014-2019
4.4.2 UK Glucagon Market Size and Price Analysis 2014-2019
4.4.3 France Glucagon Market Size and Price Analysis 2014-2019
4.4.4 Italy Glucagon Market Size and Price Analysis 2014-2019
4.4.5 Europe Glucagon Market Size and Price Analysis 2014-2019
4.5 Other Country and Region
4.5.1 Middle East Glucagon Market Size and Price Analysis 2014-2019
4.5.2 Africa Glucagon Market Size and Price Analysis 2014-2019
4.5.3 GCC Glucagon Market Size and Price Analysis 2014-2019
4.6 Global Glucagon Market Segmentation (Region Level) Analysis 2014-2019
4.7 Global Glucagon Market Segmentation (Region Level) Analysis

Section 5 Global Glucagon Market Segmentation (Product Type Level)
5.1 Global Glucagon Market Segmentation (Product Type Level) Market Size 2014-2019
5.2 Different Glucagon Product Type Price 2014-2019
5.3 Global Glucagon Market Segmentation (Product Type Level) Analysis

Section 6 Global Glucagon Market Segmentation (Industry Level)
6.1 Global Glucagon Market Segmentation (Industry Level) Market Size 2014-2019
6.2 Different Industry Price 2014-2019
6.3 Global Glucagon Market Segmentation (Industry Level) Analysis

Section 7 Global Glucagon Market Segmentation (Channel Level)
7.1 Global Glucagon Market Segmentation (Channel Level) Sales Volume and Share 2014-2019
7.2 Global Glucagon Market Segmentation (Channel Level) Analysis

Section 8 Glucagon Market Forecast 2019-2024
8.1 Glucagon Segmentation Market Forecast (Region Level)
8.2 Glucagon Segmentation Market Forecast (Product Type Level)
8.3 Glucagon Segmentation Market Forecast (Industry Level)
8.4 Glucagon Segmentation Market Forecast (Channel Level)

Section 9 Glucagon Segmentation Product Type
9.1 Inject Glucagon Product Introduction
9.2 Nasal Glucagon Product Introduction

Section 10 Glucagon Segmentation Industry
10.1 Emergency Kits Clients
10.2 General Use Clients
10.3 Diagnostic & Motility Clients
10.4 Cardiogenic Shock Clients

Section 11 Glucagon Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview

Section 12 Conclusion

Chart and Figure
Figure Glucagon Product Picture from Novo Nordisk
Chart 2014-2019 Global Manufacturer Glucagon Shipments (Units)
Chart 2014-2019 Global Manufacturer Glucagon Shipments Share
Chart 2014-2019 Global Manufacturer Glucagon Business Revenue (Million USD)
Chart 2014-2019 Global Manufacturer Glucagon Business Revenue Share
Chart Novo Nordisk Glucagon Shipments, Price, Revenue and Gross profit 2014-2019
Chart Novo Nordisk Glucagon Business Distribution
Chart Novo Nordisk Interview Record (Partly)
Figure Novo Nordisk Glucagon Product Picture
Chart Novo Nordisk Glucagon Business Profile
Table Novo Nordisk Glucagon Product Specification
Chart Eli Lilly Glucagon Shipments, Price, Revenue and Gross profit 2014-2019
Chart Eli Lilly Glucagon Business Distribution
Chart Eli Lilly Interview Record (Partly)
Figure Eli Lilly Glucagon Product Picture
Chart Eli Lilly Glucagon Business Overview
Table Eli Lilly Glucagon Product Specification
Chart Fresenius Kabi Glucagon Shipments, Price, Revenue and Gross profit 2014-2019
Chart Fresenius Kabi Glucagon Business Distribution
Chart Fresenius Kabi Interview Record (Partly)
Figure Fresenius Kabi Glucagon Product Picture
Chart Fresenius Kabi Glucagon Business Overview
Table Fresenius Kabi Glucagon Product Specification
3.4 Torrent Labs Glucagon Business Introduction

Chart United States Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart United States Glucagon Sales Price ($/Unit) 2014-2019
Chart Canada Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Canada Glucagon Sales Price ($/Unit) 2014-2019
Chart South America Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart South America Glucagon Sales Price ($/Unit) 2014-2019
Chart China Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart China Glucagon Sales Price ($/Unit) 2014-2019
Chart Japan Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Japan Glucagon Sales Price ($/Unit) 2014-2019
Chart India Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart India Glucagon Sales Price ($/Unit) 2014-2019
Chart Korea Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Korea Glucagon Sales Price ($/Unit) 2014-2019
Chart Germany Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Germany Glucagon Sales Price ($/Unit) 2014-2019
Chart UK Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart UK Glucagon Sales Price ($/Unit) 2014-2019
Chart France Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart France Glucagon Sales Price ($/Unit) 2014-2019
Chart Italy Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Italy Glucagon Sales Price ($/Unit) 2014-2019
Chart Europe Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Europe Glucagon Sales Price ($/Unit) 2014-2019
Chart Middle East Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Middle East Glucagon Sales Price ($/Unit) 2014-2019
Chart Africa Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Africa Glucagon Sales Price ($/Unit) 2014-2019
Chart GCC Glucagon Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart GCC Glucagon Sales Price ($/Unit) 2014-2019
Chart Global Glucagon Market Segmentation (Region Level) Sales Volume 2014-2019
Chart Global Glucagon Market Segmentation (Region Level) Market size 2014-2019
Chart Glucagon Market Segmentation (Product Type Level) Volume (Units) 2014-2019
Chart Glucagon Market Segmentation (Product Type Level) Market Size (Million $) 2014-2019
Chart Different Glucagon Product Type Price ($/Unit) 2014-2019
Chart Glucagon Market Segmentation (Industry Level) Market Size (Volume) 2014-2019
Chart Glucagon Market Segmentation (Industry Level) Market Size (Share) 2014-2019
Chart Glucagon Market Segmentation (Industry Level) Market Size (Value) 2014-2019
Chart Global Glucagon Market Segmentation (Channel Level) Sales Volume (Units) 2014-2019
Chart Global Glucagon Market Segmentation (Channel Level) Share 2014-2019
Chart Glucagon Segmentation Market Forecast (Region Level) 2019-2024
Chart Glucagon Segmentation Market Forecast (Product Type Level) 2019-2024
Chart Glucagon Segmentation Market Forecast (Industry Level) 2019-2024
Chart Glucagon Segmentation Market Forecast (Channel Level) 2019-2024
Chart Inject Glucagon Product Figure
Chart Inject Glucagon Product Advantage and Disadvantage Comparison
Chart Nasal Glucagon Product Figure
Chart Nasal Glucagon Product Advantage and Disadvantage Comparison
Chart Emergency Kits Clients
Chart General Use Clients
Chart Diagnostic & Motility Clients
Chart Cardiogenic Shock Clients

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.